segmented into analgesic , antidepressant , and anticonvulsants . Moreover , on the basis of distribution channel market segmented into hospitals , clinics , retails pharmacy , and online pharmacy
Geographic Coverage and Analysis : The report provides regional analysis covering geographies such as North America , Europe , Asia-Pacific , and Rest of the World . In this section the key trends and market size for each geography is provided over the period of 2017 – 2023 . North America is the largest market for diabetic neuropathy globally , with over 35 % of global market shares followed by Europe . Growth in this region is attributed to increasing numbers of diabetic cases linked with rising awareness among people about diabetes and related complication , and significant rise in research and development activities . Increasing diabetes rate in this region has surged growth for diabetic neuropathy in North America region . Furthermore , US and Canada are the major markets in this region and has played major role in the regional growth . Following North America , Europe is the second largest market for diabetic neuropathy . Asia Pacific , however , is the emerging market anticipated to grow at highest growth rate over the forecast period . This is due to increasing government support in the form of funding , developing healthcare infrastructure across the region and economic development in this region . Moreover , India is one of the dynamic markets in APAC region projected to contribute significantly in regional growth .
Companies Profiled : The companies covered in the report include Pfizer Inc , Janssen Pharmaceuticals , Inc , Eli Lilly and Company , ACTAVIS , CephalonInc , MEDA PharmaGmBH & Co . KG , GlaxoSmithKline , NeuroMetrix , Inc , and Johnson and Johnson .
Report Highlights : The report provides deep insights on demand forecasts , market trends and micro and macro indicators . In addition , this report provides insights on the factors that are driving and restraining the demand of diabetic neuropathy globally as well as regionally . Moreover , IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider . The report provides insights into the market using analytical tools such as Porter ’ s five forces analysis and DRO analysis of diabetic neuropathy . Moreover , the study highlights current market trends and provides forecast from 2017 to 2023 . We also have highlighted future trends in the diabetic neuropathy Market that will impact the demand during the forecast period . Moreover , the competitive analysis given in each regional market brings an insight on the market share of the leading players . Additionally , the analysis highlights rise and fall in the market shares of the key players in the market .
Infinium Global Research